Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 mg Clopidogrel Versus 60 mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention: The ETAMI Trial (Early...

MLA

Zeymer, Uwe, et al. “Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 Mg Clopidogrel Versus 60 Mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention: The ETAMI Trial (Early..” JACC: Cardiovascular Interventions, vol. 8, no. 1, Jan. 2015, pp. 147–54. EBSCOhost, https://doi.org/10.1016/j.jcin.2014.09.007.

APA

Zeymer, U., Mochmann, H.-C., Mark, B., Arntz, H.-R., Thiele, H., Diller, F., Montalescot, G., & Zahn, R. (2015). Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 mg Clopidogrel Versus 60 mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention: The ETAMI Trial (Early.. JACC: Cardiovascular Interventions, 8(1), 147–154. https://doi.org/10.1016/j.jcin.2014.09.007

Chicago

Zeymer, Uwe, Hans-Christian Mochmann, Bernd Mark, Hans-Richard Arntz, Holger Thiele, Frank Diller, Gilles Montalescot, and Ralf Zahn. 2015. “Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 Mg Clopidogrel Versus 60 Mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention: The ETAMI Trial (Early..” JACC: Cardiovascular Interventions 8 (1): 147–54. doi:10.1016/j.jcin.2014.09.007.